aluates Reports

$ 0.0

Automative

Global Immune Mediated Tumor Killing Assays Service Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-31D18724

BUY CHAPTERS

Global Immune Mediated Tumor Killing Assays Service Market Research Report 2025

Code: QYRE-Auto-31D18724

Report

January 2025

Pages:94

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Agilent

Laboratories

Explicyte

Reaction Biology

Axion Biosystems

Sartorius

ICE Bioscience

ProBio

Charles River

Cyagen

MarinBio

Pharmalegacy

Celentyx Ltd

Crown Bioscience

Cellomatics Biosciences

Shanghai Saily Biotechnology

Imodels

Xeno Diagnostics

Immune Mediated Tumor Killing Assays Service Market Size

The global market for Immune Mediated Tumor Killing Assays Service was valued at US$ 1390 million in the year 2024 and is projected to reach a revised size of US$ 2504 million by 2031, growing at a CAGR of 8.9% during the forecast period.

Immune Mediated Tumor Killing Assays Service Market

Immune cell killing may involve components of the innate and adaptive immune systems, including natural killer (NK) cells, cytotoxic T cells (MHC-dependent), antibodies secreted by B lymphocytes, engineered antibodies such as bispecific antibodies and bispecific T-cell engagers (BiTEs), and genetically engineered T cells directed against specific tumor antigens (e.g., CAR-T, MHC-independent).

North American market for Immune Mediated Tumor Killing Assays Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Immune Mediated Tumor Killing Assays Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Immune Mediated Tumor Killing Assays Service in Cancer Research is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Immune Mediated Tumor Killing Assays Service include Agilent, Laboratories, Explicyte, Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology, ProBio, Charles River, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Immune Mediated Tumor Killing Assays Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Mediated Tumor Killing Assays Service.

The Immune Mediated Tumor Killing Assays Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Immune Mediated Tumor Killing Assays Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Immune Mediated Tumor Killing Assays Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Immune Mediated Tumor Killing Assays Service Market Report

Report Metric	Details
Report Name	Immune Mediated Tumor Killing Assays Service Market
Accounted market size in year	US$ 1390 million
Forecasted market size in 2031	US$ 2504 million
CAGR	8.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Cytotoxic T Cell Assay Natural Killer (NK) Cell Assay Other
Segment by Application	Cancer Research Infectious Disease Research Immunotherapy Development
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Agilent, Laboratories, Explicyte, Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology, ProBio, Charles River, Imodels, Xeno Diagnostics, Cyagen, MarinBio, Pharmalegacy, Celentyx, Crown Bioscience, Cellomatics Biosciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Immune Mediated Tumor Killing Assays Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Immune Mediated Tumor Killing Assays Service Market growing?

Ans: The Immune Mediated Tumor Killing Assays Service Market witnessing a CAGR of 8.9% during the forecast period 2025-2031.

What is the Immune Mediated Tumor Killing Assays Service Market size in 2031?

Ans: The Immune Mediated Tumor Killing Assays Service Market size in 2031 will be US$ 2504 million.

Who are the main players in the Immune Mediated Tumor Killing Assays Service Market report?

Ans: The main players in the Immune Mediated Tumor Killing Assays Service Market are Agilent, Laboratories, Explicyte, Reaction Biology, Axion BioSystems, Sartorius, ICE Bioscience, Shanghai Saily Biotechnology, ProBio, Charles River, Imodels, Xeno Diagnostics, Cyagen, MarinBio, Pharmalegacy, Celentyx, Crown Bioscience, Cellomatics Biosciences

What are the Application segmentation covered in the Immune Mediated Tumor Killing Assays Service Market report?

Ans: The Applications covered in the Immune Mediated Tumor Killing Assays Service Market report are Cancer Research, Infectious Disease Research, Immunotherapy Development

What are the Type segmentation covered in the Immune Mediated Tumor Killing Assays Service Market report?

Ans: The Types covered in the Immune Mediated Tumor Killing Assays Service Market report are Cytotoxic T Cell Assay, Natural Killer (NK) Cell Assay, Other

Recommended Reports

Cancer Immunotherapies

Cancer Diagnostics

Tumor Therapy Markets

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Cytotoxic T Cell Assay

1.2.3 Natural Killer (NK) Cell Assay

1.2.4 Other

1.3 Market by Application

1.3.1 Global Immune Mediated Tumor Killing Assays Service Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer Research

1.3.3 Infectious Disease Research

1.3.4 Immunotherapy Development

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Immune Mediated Tumor Killing Assays Service Market Perspective (2020-2031)

2.2 Global Immune Mediated Tumor Killing Assays Service Growth Trends by Region

2.2.1 Global Immune Mediated Tumor Killing Assays Service Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Immune Mediated Tumor Killing Assays Service Historic Market Size by Region (2020-2025)

2.2.3 Immune Mediated Tumor Killing Assays Service Forecasted Market Size by Region (2026-2031)

2.3 Immune Mediated Tumor Killing Assays Service Market Dynamics

2.3.1 Immune Mediated Tumor Killing Assays Service Industry Trends

2.3.2 Immune Mediated Tumor Killing Assays Service Market Drivers

2.3.3 Immune Mediated Tumor Killing Assays Service Market Challenges

2.3.4 Immune Mediated Tumor Killing Assays Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Immune Mediated Tumor Killing Assays Service Players by Revenue

3.1.1 Global Top Immune Mediated Tumor Killing Assays Service Players by Revenue (2020-2025)

3.1.2 Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Players (2020-2025)

3.2 Global Immune Mediated Tumor Killing Assays Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Immune Mediated Tumor Killing Assays Service Revenue

3.4 Global Immune Mediated Tumor Killing Assays Service Market Concentration Ratio

3.4.1 Global Immune Mediated Tumor Killing Assays Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Immune Mediated Tumor Killing Assays Service Revenue in 2024

3.5 Global Key Players of Immune Mediated Tumor Killing Assays Service Head office and Area Served

3.6 Global Key Players of Immune Mediated Tumor Killing Assays Service, Product and Application

3.7 Global Key Players of Immune Mediated Tumor Killing Assays Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Immune Mediated Tumor Killing Assays Service Breakdown Data by Type

4.1 Global Immune Mediated Tumor Killing Assays Service Historic Market Size by Type (2020-2025)

4.2 Global Immune Mediated Tumor Killing Assays Service Forecasted Market Size by Type (2026-2031)

5 Immune Mediated Tumor Killing Assays Service Breakdown Data by Application

5.1 Global Immune Mediated Tumor Killing Assays Service Historic Market Size by Application (2020-2025)

5.2 Global Immune Mediated Tumor Killing Assays Service Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Immune Mediated Tumor Killing Assays Service Market Size (2020-2031)

6.2 North America Immune Mediated Tumor Killing Assays Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025)

6.4 North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Immune Mediated Tumor Killing Assays Service Market Size (2020-2031)

7.2 Europe Immune Mediated Tumor Killing Assays Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025)

7.4 Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size (2020-2031)

8.2 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size by Region (2020-2025)

8.4 Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Immune Mediated Tumor Killing Assays Service Market Size (2020-2031)

9.2 Latin America Immune Mediated Tumor Killing Assays Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025)

9.4 Latin America Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size (2020-2031)

10.2 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025)

10.4 Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Agilent

11.1.1 Agilent Company Details

11.1.2 Agilent Business Overview

11.1.3 Agilent Immune Mediated Tumor Killing Assays Service Introduction

11.1.4 Agilent Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.1.5 Agilent Recent Development

11.2 Laboratories

11.2.1 Laboratories Company Details

11.2.2 Laboratories Business Overview

11.2.3 Laboratories Immune Mediated Tumor Killing Assays Service Introduction

11.2.4 Laboratories Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.2.5 Laboratories Recent Development

11.3 Explicyte

11.3.1 Explicyte Company Details

11.3.2 Explicyte Business Overview

11.3.3 Explicyte Immune Mediated Tumor Killing Assays Service Introduction

11.3.4 Explicyte Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.3.5 Explicyte Recent Development

11.4 Reaction Biology

11.4.1 Reaction Biology Company Details

11.4.2 Reaction Biology Business Overview

11.4.3 Reaction Biology Immune Mediated Tumor Killing Assays Service Introduction

11.4.4 Reaction Biology Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.4.5 Reaction Biology Recent Development

11.5 Axion BioSystems

11.5.1 Axion BioSystems Company Details

11.5.2 Axion BioSystems Business Overview

11.5.3 Axion BioSystems Immune Mediated Tumor Killing Assays Service Introduction

11.5.4 Axion BioSystems Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.5.5 Axion BioSystems Recent Development

11.6 Sartorius

11.6.1 Sartorius Company Details

11.6.2 Sartorius Business Overview

11.6.3 Sartorius Immune Mediated Tumor Killing Assays Service Introduction

11.6.4 Sartorius Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.6.5 Sartorius Recent Development

11.7 ICE Bioscience

11.7.1 ICE Bioscience Company Details

11.7.2 ICE Bioscience Business Overview

11.7.3 ICE Bioscience Immune Mediated Tumor Killing Assays Service Introduction

11.7.4 ICE Bioscience Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.7.5 ICE Bioscience Recent Development

11.8 Shanghai Saily Biotechnology

11.8.1 Shanghai Saily Biotechnology Company Details

11.8.2 Shanghai Saily Biotechnology Business Overview

11.8.3 Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Introduction

11.8.4 Shanghai Saily Biotechnology Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.8.5 Shanghai Saily Biotechnology Recent Development

11.9 ProBio

11.9.1 ProBio Company Details

11.9.2 ProBio Business Overview

11.9.3 ProBio Immune Mediated Tumor Killing Assays Service Introduction

11.9.4 ProBio Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.9.5 ProBio Recent Development

11.10 Charles River

11.10.1 Charles River Company Details

11.10.2 Charles River Business Overview

11.10.3 Charles River Immune Mediated Tumor Killing Assays Service Introduction

11.10.4 Charles River Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.10.5 Charles River Recent Development

11.11 Imodels

11.11.1 Imodels Company Details

11.11.2 Imodels Business Overview

11.11.3 Imodels Immune Mediated Tumor Killing Assays Service Introduction

11.11.4 Imodels Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.11.5 Imodels Recent Development

11.12 Xeno Diagnostics

11.12.1 Xeno Diagnostics Company Details

11.12.2 Xeno Diagnostics Business Overview

11.12.3 Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Introduction

11.12.4 Xeno Diagnostics Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.12.5 Xeno Diagnostics Recent Development

11.13 Cyagen

11.13.1 Cyagen Company Details

11.13.2 Cyagen Business Overview

11.13.3 Cyagen Immune Mediated Tumor Killing Assays Service Introduction

11.13.4 Cyagen Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.13.5 Cyagen Recent Development

11.14 MarinBio

11.14.1 MarinBio Company Details

11.14.2 MarinBio Business Overview

11.14.3 MarinBio Immune Mediated Tumor Killing Assays Service Introduction

11.14.4 MarinBio Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.14.5 MarinBio Recent Development

11.15 Pharmalegacy

11.15.1 Pharmalegacy Company Details

11.15.2 Pharmalegacy Business Overview

11.15.3 Pharmalegacy Immune Mediated Tumor Killing Assays Service Introduction

11.15.4 Pharmalegacy Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.15.5 Pharmalegacy Recent Development

11.16 Celentyx

11.16.1 Celentyx Company Details

11.16.2 Celentyx Business Overview

11.16.3 Celentyx Immune Mediated Tumor Killing Assays Service Introduction

11.16.4 Celentyx Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.16.5 Celentyx Recent Development

11.17 Crown Bioscience

11.17.1 Crown Bioscience Company Details

11.17.2 Crown Bioscience Business Overview

11.17.3 Crown Bioscience Immune Mediated Tumor Killing Assays Service Introduction

11.17.4 Crown Bioscience Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.17.5 Crown Bioscience Recent Development

11.18 Cellomatics Biosciences

11.18.1 Cellomatics Biosciences Company Details

11.18.2 Cellomatics Biosciences Business Overview

11.18.3 Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Introduction

11.18.4 Cellomatics Biosciences Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

11.18.5 Cellomatics Biosciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Agilent

Laboratories

Explicyte

Reaction Biology

Axion Biosystems

Sartorius

ICE Bioscience

ProBio

Charles River

Cyagen

MarinBio

Pharmalegacy

Celentyx Ltd

Crown Bioscience

Cellomatics Biosciences

Shanghai Saily Biotechnology

Imodels

Xeno Diagnostics

List of Tables

Table 1. Global Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Cytotoxic T Cell Assay

Table 3. Key Players of Natural Killer (NK) Cell Assay

Table 4. Key Players of Other

Table 5. Global Immune Mediated Tumor Killing Assays Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Immune Mediated Tumor Killing Assays Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Immune Mediated Tumor Killing Assays Service Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Immune Mediated Tumor Killing Assays Service Market Share by Region (2020-2025)

Table 9. Global Immune Mediated Tumor Killing Assays Service Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Immune Mediated Tumor Killing Assays Service Market Share by Region (2026-2031)

Table 11. Immune Mediated Tumor Killing Assays Service Market Trends

Table 12. Immune Mediated Tumor Killing Assays Service Market Drivers

Table 13. Immune Mediated Tumor Killing Assays Service Market Challenges

Table 14. Immune Mediated Tumor Killing Assays Service Market Restraints

Table 15. Global Immune Mediated Tumor Killing Assays Service Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Immune Mediated Tumor Killing Assays Service Market Share by Players (2020-2025)

Table 17. Global Top Immune Mediated Tumor Killing Assays Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Mediated Tumor Killing Assays Service as of 2024)

Table 18. Ranking of Global Top Immune Mediated Tumor Killing Assays Service Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Immune Mediated Tumor Killing Assays Service Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Immune Mediated Tumor Killing Assays Service, Headquarters and Area Served

Table 21. Global Key Players of Immune Mediated Tumor Killing Assays Service, Product and Application

Table 22. Global Key Players of Immune Mediated Tumor Killing Assays Service, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Immune Mediated Tumor Killing Assays Service Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Type (2020-2025)

Table 26. Global Immune Mediated Tumor Killing Assays Service Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Type (2026-2031)

Table 28. Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Application (2020-2025)

Table 30. Global Immune Mediated Tumor Killing Assays Service Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Immune Mediated Tumor Killing Assays Service Revenue Market Share by Application (2026-2031)

Table 32. North America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size by Country (2026-2031) & (US$ Million)

Table 47. Agilent Company Details

Table 48. Agilent Business Overview

Table 49. Agilent Immune Mediated Tumor Killing Assays Service Product

Table 50. Agilent Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 51. Agilent Recent Development

Table 52. Laboratories Company Details

Table 53. Laboratories Business Overview

Table 54. Laboratories Immune Mediated Tumor Killing Assays Service Product

Table 55. Laboratories Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 56. Laboratories Recent Development

Table 57. Explicyte Company Details

Table 58. Explicyte Business Overview

Table 59. Explicyte Immune Mediated Tumor Killing Assays Service Product

Table 60. Explicyte Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 61. Explicyte Recent Development

Table 62. Reaction Biology Company Details

Table 63. Reaction Biology Business Overview

Table 64. Reaction Biology Immune Mediated Tumor Killing Assays Service Product

Table 65. Reaction Biology Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 66. Reaction Biology Recent Development

Table 67. Axion BioSystems Company Details

Table 68. Axion BioSystems Business Overview

Table 69. Axion BioSystems Immune Mediated Tumor Killing Assays Service Product

Table 70. Axion BioSystems Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 71. Axion BioSystems Recent Development

Table 72. Sartorius Company Details

Table 73. Sartorius Business Overview

Table 74. Sartorius Immune Mediated Tumor Killing Assays Service Product

Table 75. Sartorius Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 76. Sartorius Recent Development

Table 77. ICE Bioscience Company Details

Table 78. ICE Bioscience Business Overview

Table 79. ICE Bioscience Immune Mediated Tumor Killing Assays Service Product

Table 80. ICE Bioscience Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 81. ICE Bioscience Recent Development

Table 82. Shanghai Saily Biotechnology Company Details

Table 83. Shanghai Saily Biotechnology Business Overview

Table 84. Shanghai Saily Biotechnology Immune Mediated Tumor Killing Assays Service Product

Table 85. Shanghai Saily Biotechnology Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 86. Shanghai Saily Biotechnology Recent Development

Table 87. ProBio Company Details

Table 88. ProBio Business Overview

Table 89. ProBio Immune Mediated Tumor Killing Assays Service Product

Table 90. ProBio Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 91. ProBio Recent Development

Table 92. Charles River Company Details

Table 93. Charles River Business Overview

Table 94. Charles River Immune Mediated Tumor Killing Assays Service Product

Table 95. Charles River Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 96. Charles River Recent Development

Table 97. Imodels Company Details

Table 98. Imodels Business Overview

Table 99. Imodels Immune Mediated Tumor Killing Assays Service Product

Table 100. Imodels Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 101. Imodels Recent Development

Table 102. Xeno Diagnostics Company Details

Table 103. Xeno Diagnostics Business Overview

Table 104. Xeno Diagnostics Immune Mediated Tumor Killing Assays Service Product

Table 105. Xeno Diagnostics Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 106. Xeno Diagnostics Recent Development

Table 107. Cyagen Company Details

Table 108. Cyagen Business Overview

Table 109. Cyagen Immune Mediated Tumor Killing Assays Service Product

Table 110. Cyagen Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 111. Cyagen Recent Development

Table 112. MarinBio Company Details

Table 113. MarinBio Business Overview

Table 114. MarinBio Immune Mediated Tumor Killing Assays Service Product

Table 115. MarinBio Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 116. MarinBio Recent Development

Table 117. Pharmalegacy Company Details

Table 118. Pharmalegacy Business Overview

Table 119. Pharmalegacy Immune Mediated Tumor Killing Assays Service Product

Table 120. Pharmalegacy Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 121. Pharmalegacy Recent Development

Table 122. Celentyx Company Details

Table 123. Celentyx Business Overview

Table 124. Celentyx Immune Mediated Tumor Killing Assays Service Product

Table 125. Celentyx Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 126. Celentyx Recent Development

Table 127. Crown Bioscience Company Details

Table 128. Crown Bioscience Business Overview

Table 129. Crown Bioscience Immune Mediated Tumor Killing Assays Service Product

Table 130. Crown Bioscience Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 131. Crown Bioscience Recent Development

Table 132. Cellomatics Biosciences Company Details

Table 133. Cellomatics Biosciences Business Overview

Table 134. Cellomatics Biosciences Immune Mediated Tumor Killing Assays Service Product

Table 135. Cellomatics Biosciences Revenue in Immune Mediated Tumor Killing Assays Service Business (2020-2025) & (US$ Million)

Table 136. Cellomatics Biosciences Recent Development

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

Table 140. Authors List of This Report

List of Figures

Figure 1. Immune Mediated Tumor Killing Assays Service Picture

Figure 2. Global Immune Mediated Tumor Killing Assays Service Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Immune Mediated Tumor Killing Assays Service Market Share by Type: 2024 VS 2031

Figure 4. Cytotoxic T Cell Assay Features

Figure 5. Natural Killer (NK) Cell Assay Features

Figure 6. Other Features

Figure 7. Global Immune Mediated Tumor Killing Assays Service Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Immune Mediated Tumor Killing Assays Service Market Share by Application: 2024 VS 2031

Figure 9. Cancer Research Case Studies

Figure 10. Infectious Disease Research Case Studies

Figure 11. Immunotherapy Development Case Studies

Figure 12. Immune Mediated Tumor Killing Assays Service Report Years Considered

Figure 13. Global Immune Mediated Tumor Killing Assays Service Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Immune Mediated Tumor Killing Assays Service Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Immune Mediated Tumor Killing Assays Service Market Share by Region: 2024 VS 2031

Figure 16. Global Immune Mediated Tumor Killing Assays Service Market Share by Players in 2024

Figure 17. Global Top Immune Mediated Tumor Killing Assays Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Mediated Tumor Killing Assays Service as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Immune Mediated Tumor Killing Assays Service Revenue in 2024

Figure 19. North America Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Immune Mediated Tumor Killing Assays Service Market Share by Country (2020-2031)

Figure 21. United States Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Immune Mediated Tumor Killing Assays Service Market Share by Country (2020-2031)

Figure 25. Germany Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Immune Mediated Tumor Killing Assays Service Market Share by Region (2020-2031)

Figure 33. China Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Immune Mediated Tumor Killing Assays Service Market Share by Country (2020-2031)

Figure 41. Mexico Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Immune Mediated Tumor Killing Assays Service Market Share by Country (2020-2031)

Figure 45. Turkey Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Immune Mediated Tumor Killing Assays Service Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Agilent Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 49. Laboratories Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 50. Explicyte Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 51. Reaction Biology Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 52. Axion BioSystems Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 53. Sartorius Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 54. ICE Bioscience Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 55. Shanghai Saily Biotechnology Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 56. ProBio Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 57. Charles River Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 58. Imodels Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 59. Xeno Diagnostics Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 60. Cyagen Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 61. MarinBio Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 62. Pharmalegacy Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 63. Celentyx Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 64. Crown Bioscience Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 65. Cellomatics Biosciences Revenue Growth Rate in Immune Mediated Tumor Killing Assays Service Business (2020-2025)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Tumor Immune Cell Therapy Market Research Report 2024

Natural Killer NK Cell Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global T cell Engaging bsAbs Market Research Report 2025

Global NK Cell Cytotoxicity Assay Service Market Research Report 2025

Global Cytotoxic T Cells CTL Market Research Report 2024

Global T cell Engaging bsAbs Drugs Market Research Report 2025

Antibody Therapeutics and Blood Antibody Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Natural Killer Cells Therapeutics Market Insights Forecast to 2030

Global T cell Bispecific Antibodies Drug Market Research Report 2025

Global Drug based on CAR T Cell Market Research Report 2025

Global Drugs Based on CAR T cell Market Research Report 2025

Global Cell bridging Bispecific Antibodies Market Research Report 2025

Global Gene Modifying Immunotherapy for Blood Cancer Market Insights Forecast to 2030

Global K Cells Market Research Report 2024

Engineered Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CD19 targeted CAR T Cell Therapy Market Research Report 2024

Global Combination Antibody Therapy Market Research Report 2024

Global CAR T cell Therapy Drug Market Research Report 2025

Global CAR T Cell Therapy Agents Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions